THE HSP90-SPECIFIC INHIBITOR, GELDANAMYCIN, BLOCKS CD28-MEDIATED ACTIVATION OF HUMAN T-LYMPHOCYTES

Citation
T. Schnaider et al., THE HSP90-SPECIFIC INHIBITOR, GELDANAMYCIN, BLOCKS CD28-MEDIATED ACTIVATION OF HUMAN T-LYMPHOCYTES, Life sciences (1973), 63(11), 1998, pp. 949-954
Citations number
23
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Journal title
ISSN journal
00243205
Volume
63
Issue
11
Year of publication
1998
Pages
949 - 954
Database
ISI
SICI code
0024-3205(1998)63:11<949:THIGBC>2.0.ZU;2-1
Abstract
The 90 kDa heat shock protein (Hsp90) is a molecular chaperone aiding the folding of nuclear hormone receptors and protein kinases. Hsp90-me diated folding can be disrupted by the Hsp90-specific drug, geldanamyc in. Here we provide evidence for the inhibition of the CD28-specific B W 828 antibody-mediated activation of human T lymphocyte proliferation , IL-2 secretion and IL-2 receptor expression by geldanamycin. Our res ults suggest that the major cytoplasmic chaperone, Hsp90, plays an imp ortant role in CD28-mediated T lymphocyte activation.